nafamostat and dinoprostone

nafamostat has been researched along with dinoprostone in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hatakeyama, H; Ikeda, J; Kojima, S; Kuramochi, M; Naganawa, M; Ogi, M; Yoshitomi, Y	1
Iwagaki, H; Jikuhara, A; Mori, S; Nishibori, M; Takahashi, HK; Tanaka, N; Yoshii, M	1

Other Studies

2 other study(ies) available for nafamostat and dinoprostone

Article	Year
Changes in bradykinin and prostaglandins plasma levels during dextran-sulfate low-density-lipoprotein apheresis. The International journal of artificial organs, 1997, Volume: 20, Issue:3 Topics: 6-Ketoprostaglandin F1 alpha; Anticoagulants; Benzamidines; Blood Component Removal; Bradykinin; Cyclic GMP; Dextran Sulfate; Dinoprostone; Factor XII; Guanidines; Heparin; Humans; Hyperlipoproteinemia Type II; Kallikreins; Kininogens; Lipoproteins, LDL; Male; Middle Aged; Prekallikrein	1997
Mast cell tryptase stimulates DLD-1 carcinoma through prostaglandin- and MAP kinase-dependent manners. Journal of pharmacological sciences, 2005, Volume: 98, Issue:4 Topics: Benzamidines; Calcium; Carcinoma; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclooxygenase Inhibitors; Cytosol; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Guanidines; Humans; Immunohistochemistry; Indomethacin; Mast Cells; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Nitrobenzenes; Phosphorylation; Prostaglandins; Receptor, PAR-2; Serine Endopeptidases; Sulfonamides; Tryptases	2005

Article

Year

Changes in bradykinin and prostaglandins plasma levels during dextran-sulfate low-density-lipoprotein apheresis.

The International journal of artificial organs, 1997, Volume: 20, Issue:3

Topics: 6-Ketoprostaglandin F1 alpha; Anticoagulants; Benzamidines; Blood Component Removal; Bradykinin; Cyclic GMP; Dextran Sulfate; Dinoprostone; Factor XII; Guanidines; Heparin; Humans; Hyperlipoproteinemia Type II; Kallikreins; Kininogens; Lipoproteins, LDL; Male; Middle Aged; Prekallikrein

1997

Mast cell tryptase stimulates DLD-1 carcinoma through prostaglandin- and MAP kinase-dependent manners.

Journal of pharmacological sciences, 2005, Volume: 98, Issue:4

Topics: Benzamidines; Calcium; Carcinoma; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclooxygenase Inhibitors; Cytosol; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Guanidines; Humans; Immunohistochemistry; Indomethacin; Mast Cells; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Nitrobenzenes; Phosphorylation; Prostaglandins; Receptor, PAR-2; Serine Endopeptidases; Sulfonamides; Tryptases

2005